EBV LMP2A anticorps
Aperçu rapide pour EBV LMP2A anticorps (ABIN644979)
Antigène
Reactivité
Hôte
Conjugué
Application
-
-
Specificité
- DS-MB-03627 recognizes latent membrane protein 2A (LMP2A) of Epstein-Barr virus (EBV). EBV is a human herpes virus, which is associated with conditions such as Hodgkin's disease and Burkitt's Lymphoma and is the causative agent in mononucleosis in adolescents. EBV latently infects B lymphocytes. Infected B cells express EBV nuclear antigens and latent proteins LMP1, LMP2A and LMP2B. LMP2A forms aggregates in the plasma membranes of B lymphocytes, where it functions as a negative regulator of the Src and Syk protein tyrosine kinases. Studies show that LMP2A blocks B-cell receptor (BCR) signal transduction in EBV immortalized B cells in vitro and may play an important role in maintaining a latent EBV infection within the peripheral blood B cells of infected individuals. DS-MB-03627 specifically recognizes LMP2A and does not cross react with LMP2B.
-
Attributs du produit
- Rat Anti-Epstein-Barr Virus LMP2A
-
Purification
- Purified
-
Immunogène
- Bacterial TrpE-LMP2A fusion protein
-
Isotype
- IgG2a
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Concentration
- IgG concentration 1.0 mg/ml
-
Buffer
- Phosphate buffered saline
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
-
- EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
-
Autre désignation
- Epstein-Barr Virus LMP2A
-
Classe de substances
- Viral Protein
Antigène
-